Related Experiment Video
Updated: Feb 14, 2026

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
Published on: June 28, 2021
Ibrutinib presents antitumor activity in skin cancer and induces autophagy
1Department of Pharmacy, Yantai Yuhuangding Hospital, Yantai, China. zshzqf@163.com.
Objective:
Skin cancer is one of the most common malignancies in dermatology. Patient compliance and prognosis of skin cancer are poor. Ibrutinib, a Bruton's Tyrosine Kinase (BTK) inhibitor, is a new anticancer drug used to treat many cancers. Therefore, we aimed to explore the role of ibrutinib in the treatment of skin cancer.
Materials And Methods:
Cell Counting Kit-8 (CCK8) and plate cloning assay were used to detect cell proliferation. Apoptosis was determined by flow cytometry. Western blotting analysis was used to analyze the expression of key proteins that regulated autophagy. Proliferation and apoptosis of skin cancer cells and induction of autophagy induced by ibrutinib were evaluated.
Results:
CCK8 plate cloning assays showed that ibrutinib can gradually inhibit the skin cancer cell proliferation as the treatment time and dose increased. Results of flow cytometry showed that apoptosis in skin cancer cells were induced after ibrutinib treatment. Western blot showed that autophagy in skin cancer cells was found induced by ibrutinib and also related to the time and concentration of ibrutinib treatment. Combination treatment of ibrutinib and 3MA for skin cancer cells can significantly increase apoptosis.
Conclusions:
Ibrutinib has anti-tumor activity in skin cancer and can induce autophagy. Binding to autophagy inhibitors can promote ibrutinib's anti-skin cancer activity. Our experimental results provided new ideas for developing skin cancer drugs.
Insights
Ibrutinib, a Bruton's Tyrosine Kinase (BTK) inhibitor, inhibits skin cancer cell proliferation and induces apoptosis and autophagy. Combining ibrutinib with autophagy inhibitors enhances its anti-cancer effects, offering new therapeutic strategies for skin cancer.
Area of Science:
- Dermatology
- Oncology
- Molecular Biology
Background:
- Skin cancer is a prevalent malignancy with poor patient prognosis.
- Ibrutinib, a Bruton's Tyrosine Kinase (BTK) inhibitor, shows promise as an anticancer agent.
- Investigating ibrutinib's efficacy in skin cancer treatment is crucial.
Purpose of the Study:
- To explore the anti-tumor activity of ibrutinib in skin cancer.
- To evaluate ibrutinib's effects on skin cancer cell proliferation, apoptosis, and autophagy.
- To assess the potential of combining ibrutinib with autophagy inhibitors.
Main Methods:
- Cell Counting Kit-8 (CCK8) and plate cloning assays for proliferation.
- Flow cytometry for apoptosis analysis.
- Western blotting for autophagy-related protein expression.
Main Results:
- Ibrutinib demonstrated dose- and time-dependent inhibition of skin cancer cell proliferation.
- Ibrutinib treatment induced apoptosis in skin cancer cells.
- Ibrutinib was found to induce autophagy in skin cancer cells, dependent on concentration and time.
- Combination therapy with ibrutinib and 3MA significantly increased apoptosis.
Conclusions:
- Ibrutinib exhibits anti-tumor activity against skin cancer by inducing autophagy.
- Combining ibrutinib with autophagy inhibitors can enhance its anti-skin cancer efficacy.
- These findings offer novel therapeutic avenues for skin cancer drug development.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Mechanisms of Retrovirus-induced Cancers
Sensory Functions of the Skin
There are two main categories of receptors on the skin: capsulated and non-capsulated. The non-capsulated ones are mainly the pain receptors. The capsulated ones can be further categorized based on the...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...

